Close

Intrexon (XON) on Watch as FDA Green Lights GM Mosquitoes

Go back to Intrexon (XON) on Watch as FDA Green Lights GM Mosquitoes

Intrexon (XON)/Oxitec Announces FDA Finds No Significant Impact From Self-limiting Mosquito

August 5, 2016 10:43 AM EDT

The US Food and Drug Administration's Center for Veterinary Medicine (FDA-CVM) today published a final finding of no significant impact (FONSI) and final environmental assessment (EA) on Oxitec's self-limiting OX513A Aedes aegypti mosquito for an investigational trial in the Florida Keys. The finding concludes that a field trial of the Company's genetically engineered (GE) OX513A mosquitoes in Key Haven, Florida, will not result in a significant impact on the environment.

The publication of the final FONSI and EA follows an FDA-led evaluation of potential impacts on health and the environment of the proposed trial. This... More